Titan Pharmaceuticals, Inc.

NASDAQ: TTNP    
Share price (4/26/24): $7.09    
Market cap (4/26/24): $6.482 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 2 pages State of Delaware Secretary of State Division of Corporations Delivered 09:49 Am 01/08/2024 Filed 09:49 Am 01/08/2024 Sr 20240054446 – File Number 2287466 Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Titan Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 1 page Amendment to the Bylaws of Titan Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 1 page Amendment to the Bylaws of Titan Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages Form of Certificate of Amendment to the Restated Certificate of Incorporation of Titan Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Restated Certificate of Incorporation of Titan Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 13 pages Titan Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.3
from S-1/A 13 pages Titan Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.3
from S-3 12 pages Bylaws of Titan Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Restated Certificate of Incorporation of Titan Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 8 pages Certificate of Designations of Junior Participating Preferred Stock of Titan Pharmaceuticals, Inc
12/34/56
EX-3.1
from 10-12G 7 pages Amended and Restated Certificate of Incorporation of Titan Pharmaceuticals, Inc
12/34/56